These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 20163430)

  • 1. Mechanisms of disease and clinical features of mutations of the gene for mitofusin 2: an important cause of hereditary peripheral neuropathy with striking clinical variability in children and adults.
    Ouvrier R; Grew S
    Dev Med Child Neurol; 2010 Apr; 52(4):328-30. PubMed ID: 20163430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early onset severe and late-onset mild Charcot-Marie-Tooth disease with mitofusin 2 (MFN2) mutations.
    Chung KW; Kim SB; Park KD; Choi KG; Lee JH; Eun HW; Suh JS; Hwang JH; Kim WK; Seo BC; Kim SH; Son IH; Kim SM; Sunwoo IN; Choi BO
    Brain; 2006 Aug; 129(Pt 8):2103-18. PubMed ID: 16835246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Axonal neuropathy with optic atrophy is caused by mutations in mitofusin 2.
    Züchner S; De Jonghe P; Jordanova A; Claeys KG; Guergueltcheva V; Cherninkova S; Hamilton SR; Van Stavern G; Krajewski KM; Stajich J; Tournev I; Verhoeven K; Langerhorst CT; de Visser M; Baas F; Bird T; Timmerman V; Shy M; Vance JM
    Ann Neurol; 2006 Feb; 59(2):276-81. PubMed ID: 16437557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of mitofusin 2 mutations in the physiopathology of Charcot-Marie-Tooth disease type 2A.
    Cartoni R; Martinou JC
    Exp Neurol; 2009 Aug; 218(2):268-73. PubMed ID: 19427854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genotype-phenotype correlations in Charcot-Marie-Tooth disease type 2 caused by mitofusin 2 mutations.
    Calvo J; Funalot B; Ouvrier RA; Lazaro L; Toutain A; De Mas P; Bouche P; Gilbert-Dussardier B; Arne-Bes MC; Carrière JP; Journel H; Minot-Myhie MC; Guillou C; Ghorab K; Magy L; Sturtz F; Vallat JM; Magdelaine C
    Arch Neurol; 2009 Dec; 66(12):1511-6. PubMed ID: 20008656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and electrophysiologic features of CMT2A with mutations in the mitofusin 2 gene.
    Lawson VH; Graham BV; Flanigan KM
    Neurology; 2005 Jul; 65(2):197-204. PubMed ID: 16043786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molecular genetics of inherited neuropathies].
    Takashima H
    Rinsho Shinkeigaku; 2006 Jan; 46(1):1-18. PubMed ID: 16541790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Charcot-Marie-Tooth neuropathy type 2A: novel mutations in the mitofusin 2 gene (MFN2).
    Engelfried K; Vorgerd M; Hagedorn M; Haas G; Gilles J; Epplen JT; Meins M
    BMC Med Genet; 2006 Jun; 7():53. PubMed ID: 16762064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ultrastructural lesions of axonal mitochondria in patients with childhood-onset Charcot-Marie-Tooth disease due to MFN2 mutations].
    Funalot B; Magdelaine C; Sturtz F; Ouvrier R; Vallat JM
    Bull Acad Natl Med; 2009 Jan; 193(1):151-60; discussion 160-1. PubMed ID: 19718987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mutations in the mitofusin 2 gene are the most common cause of Charcot-Marie-Tooth type 2 disease].
    Sołtysińska E; Kabzińska D; Kochański A
    Neurol Neurochir Pol; 2007; 41(4):350-4. PubMed ID: 17874344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial dynamics and inherited peripheral nerve diseases.
    Pareyson D; Saveri P; Sagnelli A; Piscosquito G
    Neurosci Lett; 2015 Jun; 596():66-77. PubMed ID: 25847151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic spectrum of MFN2 mutations in the Spanish population.
    Casasnovas C; Banchs I; Cassereau J; Gueguen N; Chevrollier A; Martínez-Matos JA; Bonneau D; Volpini V
    J Med Genet; 2010 Apr; 47(4):249-56. PubMed ID: 19889647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-occurrence of amyotrophic lateral sclerosis and Charcot-Marie-Tooth disease type 2A in a patient with a novel mutation in the mitofusin-2 gene.
    Marchesi C; Ciano C; Salsano E; Nanetti L; Milani M; Gellera C; Taroni F; Fabrizi GM; Uncini A; Pareyson D
    Neuromuscul Disord; 2011 Feb; 21(2):129-31. PubMed ID: 20951041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterizing the phenotypic manifestations of MFN2 R104W mutation in Charcot-Marie-Tooth type 2.
    Genari AB; Borghetti VH; Gouvêa SP; Bueno KC; dos Santos PL; dos Santos AC; Barreira AA; Lourenço CM; Marques W
    Neuromuscul Disord; 2011 Jun; 21(6):428-32. PubMed ID: 21531138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A French family with Charcot-Marie-Tooth disease related to simultaneous heterozygous MFN2 and GDAP1 mutations.
    Vital A; Latour P; Sole G; Ferrer X; Rouanet M; Tison F; Vital C; Goizet C
    Neuromuscul Disord; 2012 Aug; 22(8):735-41. PubMed ID: 22546700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MFN2 mutation distribution and genotype/phenotype correlation in Charcot-Marie-Tooth type 2.
    Verhoeven K; Claeys KG; Züchner S; Schröder JM; Weis J; Ceuterick C; Jordanova A; Nelis E; De Vriendt E; Van Hul M; Seeman P; Mazanec R; Saifi GM; Szigeti K; Mancias P; Butler IJ; Kochanski A; Ryniewicz B; De Bleecker J; Van den Bergh P; Verellen C; Van Coster R; Goemans N; Auer-Grumbach M; Robberecht W; Milic Rasic V; Nevo Y; Tournev I; Guergueltcheva V; Roelens F; Vieregge P; Vinci P; Moreno MT; Christen HJ; Shy ME; Lupski JR; Vance JM; De Jonghe P; Timmerman V
    Brain; 2006 Aug; 129(Pt 8):2093-102. PubMed ID: 16714318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two Spanish families with Charcot-Marie-Tooth type 2A: clinical, electrophysiological and molecular findings.
    Banchs I; Casasnovas C; Montero J; Martínez-Matos JA; Volpini V
    Neuromuscul Disord; 2008 Dec; 18(12):974-8. PubMed ID: 18996695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of mitofusin 2(R94Q) in a transgenic mouse leads to Charcot-Marie-Tooth neuropathy type 2A.
    Cartoni R; Arnaud E; Médard JJ; Poirot O; Courvoisier DS; Chrast R; Martinou JC
    Brain; 2010 May; 133(Pt 5):1460-9. PubMed ID: 20418531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Charcot-Marie-Tooth disease type 2A: from typical to rare phenotypic and genotypic features.
    Bombelli F; Stojkovic T; Dubourg O; Echaniz-Laguna A; Tardieu S; Larcher K; Amati-Bonneau P; Latour P; Vignal O; Cazeneuve C; Brice A; Leguern E
    JAMA Neurol; 2014 Aug; 71(8):1036-42. PubMed ID: 24957169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe early-onset axonal neuropathy with homozygous and compound heterozygous MFN2 mutations.
    Nicholson GA; Magdelaine C; Zhu D; Grew S; Ryan MM; Sturtz F; Vallat JM; Ouvrier RA
    Neurology; 2008 May; 70(19):1678-81. PubMed ID: 18458227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.